Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...

Scribe Therapeutics hopes to prevent cardiometabolic diseases by targeting underlying causes with CRISPR technology.

First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 ...

Variant Bio recently announced a multimillion-dollar deal with a pharmaceutical company, and some of that money will go to ...

Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. The ...

I will start by saying that biotechnology is a game Changer, it has revolutionised various fields, including medicare, agricultural business, industrial engineering and environmental science, ...

APW High School has partnered with local biotech company BioSpherix to enhance students' STEM education through the donation ...

Synthetic biologists from Yale were able to re-write the genetic code of an organism - a novel genomically recoded organism (GRO) with one stop codon - using a cellular platform that they developed ...

A new study has unveiled the genetic mechanism controlling citric acid content in jujube fruit, identifying a natural ...